MAPT and cancer: In addition, our successful application of RAP-MS method in identification of Tau splicing factors indicates that RAP-MS can be routinely used as a sensitive and comprehensive tool to unveil in situ splicing factors that mediate aberrant splicing events clinically linked with human diseases such as cancer and neurodegeneration.